What Is Nicotine Withdrawal Syndrome?
Nicotine withdrawal syndrome is the set of physical and psychological symptoms that arise when a smoker stops or significantly reduces tobacco use. It is a direct manifestation of the neurochemical dependence that nicotine produces in the brain — and it represents the main barrier to smoking cessation.
Smoking is recognized by the WHO as a chronic disease of dependence, classified in ICD-11 as Tobacco Use Disorder. Nicotine is one of the most addictive substances known — with high dependence potential, comparable to or greater than that of other psychoactive substances on some epidemiological measures. About 70% of smokers want to quit, but only 3-5% succeed without help.
Understanding withdrawal as a neurobiological phenomenon — not as a "lack of willpower" — is essential só smokers seek and receive the right treatment. Effective treatments exist that triple the chances of successful cessation.
Neurochemical Dependence
Nicotine permanently rewires dopaminergic reward circuits, creating physical and psychological dependence that explains why quitting is só hard.
Temporary Symptoms
Physical withdrawal peaks at 2-3 days and improves significantly within 2-4 weeks. Symptoms are temporary but intense.
Effective Treatment
Nicotine replacement therapy, varenicline, and bupropion triple the chances of cessation. Adequate support makes all the difference.
Pathophysiology
Nicotine reaches the brain within 7-10 seconds after inhalation, binding to nicotinic acetylcholine receptors (nAChR) in the mesolimbic reward system. This triggers dopamine release in the nucleus accumbens — the same circuit activated by other drugs of abuse — producing pleasure and stress relief.
Neuroadaptation and Tolerance
With chronic exposure, the brain undergoes neuroadaptation: there is an increase in the number of nicotinic receptors (upregulation) to compensate for continuous desensitization. When the smoker stops smoking, these supernumerary receptors remain unoccupied, generating a state of dopaminergic hypoactivity that manifests as discomfort, irritability, and craving.
Multiple Neurotransmitters
Beyond dopamine, nicotine modulates the release of norepinephrine (alertness and concentration), serotonin (mood), GABA (relaxation), glutamate (memory), and endorphins (analgesia). Withdrawal affects all of these systems simultaneously, explaining the diversity of symptoms.
Symptoms
Withdrawal symptoms begin 2-12 hours after the last cigarette, peak at 24-72 hours, and gradually improve over 2-4 weeks. Some symptoms, such as craving and increased appetite, can persist for months. Intensity varies with the degree of dependence.
Symptoms of Nicotine Withdrawal
- 01
Intense craving for tobacco
Urgent, overwhelming urge to smoke. Each episode typically lasts 3-5 minutes but can be very intense — the leading cause of relapse.
- 02
Irritability, frustration, or anger
One of the most common and disruptive symptoms. It can significantly strain relationships and the workplace during the first weeks.
- 03
Anxiety
Paradoxically, anxiety worsens in the first weeks of cessation before improving. Nicotine was used as an "anxiolytic," and its withdrawal unmasks underlying anxiety.
- 04
Difficulty concentrating
Transient attentional déficit driven by reduced norepinephrine. It can impair work performance during the first 2-3 weeks.
- 05
Depressed mood
Lower dopamine causes transient anhedonia. In people with a history of depression, it can trigger a depressive episode.
- 06
Insomnia or sleep disturbances
Difficulty falling asleep, fragmented sleep, vivid dreams (especially with nicotine replacement). Improves in 1-2 weeks.
- 07
Increased appetite and weight gain
Average gain of 4-5 kg in the first months. Driven by increased appetite, a slower metabolism, and replacing the oral habit.
- 08
Restlessness
An inability to stay still, with motor agitation. Linked to dopaminergic hypoactivity.
- 09
Constipation
Nicotine stimulates intestinal peristalsis. Withdrawal can cause transient constipation for 1-2 weeks.
Diagnosis
Diagnosing nicotine dependence and the withdrawal syndrome is clinical. The Fagerstrom Test for Nicotine Dependence (FTND) is the most widely used instrument to assess the degree of dependence and guide treatment selection. Serum or urinary cotinine can objectively confirm tobacco use.
🏥DSM-5 Criteria for Tobacco Withdrawal
Fonte: American Psychiatric Association — DSM-5
Criterion A: Daily tobacco use for at least several weeks
- 1.Daily tobacco use for a prolonged period before abrupt cessation or reduction
Criterion B: 4 or more symptoms within 24h after cessation
At least 4 symptoms must be present- 1.Irritability, frustration, or anger
- 2.Anxiety
- 3.Difficulty concentrating
- 4.Increased appetite
- 5.Restlessness
- 6.Depressed mood
- 7.Insomnia
Additional criteria
- 1.Symptoms cause clinically significant distress or functional impairment
- 2.Symptoms are not attributable to another medical condition or mental disorder
FAGERSTROM TEST — DEGREES OF DEPENDENCE
| SCORE | DEGREE OF DEPENDENCE | CLINICAL IMPLICATIONS |
|---|---|---|
| 0-2 | Low | May attempt cessation without pharmacotherapy. Behavioral support may be sufficient. |
| 3-4 | Moderate | Pharmacotherapy recommended. NRT at standard doses or bupropion. |
| 5-6 | High | Pharmacotherapy essential. Consider combination treatment. NRT at higher doses. |
| 7-10 | Very high | Combination therapy (NRT + bupropion or varenicline). Intensive follow-up. |
DIFFERENTIAL DIAGNOSIS
Differential Diagnosis
Depression
Read more →- Depressed mood persisting beyond the withdrawal period
- Generalized anhedonia
- Does not improve after weeks without smoking
Diagnostic Tests
- PHQ-9
- Interview
GAD
Read more →- Anxiety persisting beyond withdrawal
- Multiple domains of worry
- Does not resolve after adaptation to withdrawal
Diagnostic Tests
- GAD-7
Hypothyroidism (cause of weight gain)
- Disproportionate weight gain after cessation
- Persistent fatigue
- Abnormal TSH
Diagnostic Tests
- TSH
Withdrawal Syndrome from Another Substance
- Concurrent use of alcohol/anxiolytics
- Symptoms more severe than expected for tobacco
Diagnostic Tests
- Substance screening
Occupational Stress/Burnout
Read more →- Irritability and craving tied to the work context
- Worsening in work situations
Diagnostic Tests
- Occupational evaluation
- MBI
Depression and Anxiety in Smoking Cessation
Quitting smoking can precipitate or unmask underlying depression and anxiety. Nicotine acts as both an antidepressant and anxiolytic, raising dopamine, serotonin, and norepinephrine. When smoking stops, the loss of those neurobiological effects can trigger depressed mood, anhedonia, and heightened anxiety, especially in the first 2-4 weeks. The clinical question becomes: are these symptoms nicotine withdrawal, or an underlying psychiatric disorder?
Nicotine withdrawal peaks in the first 3-5 days and steadily improves over 2-4 weeks. If depressed mood, intense anhedonia, or anxiety persist past 4 weeks, investigate an underlying psychiatric disorder. PHQ-9 and GAD-7 are quick screening scales. Bupropion — a cessation pharmacotherapy — is also an antidepressant, só it can mask underlying depression while cessation treatment is active.
Weight Gain and Hypothyroidism
Weight gain after quitting is expected — about 4-5 kg in the first 6-12 months. Nicotine suppresses appetite, raises basal metabolism, and lowers metabolic efficiency; without it, metabolism slows and appetite climbs. The gain is predictable and clinically far smaller than the ongoing risks of smoking.
When weight gain is disproportionate (over 8-10 kg) or paired with persistent fatigue, cold intolerance, and other complaints, rule out hypothyroidism. A simple TSH guides the diagnosis. Smoking can mask hypothyroidism (nicotine interferes with thyroid metabolism), and the condition often becomes symptomatic after quitting. Treating hypothyroidism helps maintain abstinence by resolving the fatigue.
Context-Linked Craving and Polysubstance Use
Tobacco craving can be intense and is triggered by specific contexts: work stress, coffee or alcohol, post-meal moments, social situations. When craving and irritability are driven mainly by work, evaluate burnout or job stress as a precipitating factor — treating the stressor can reduce situational craving.
Polysubstance use complicates smoking cessation. Concurrent alcohol use cuts the chance of successful cessation by up to 50% — alcohol is a potent smoking trigger. Benzodiazepines may mask early withdrawal symptoms. Screen for other substances (AUDIT for alcohol, ASSIST) in patients with withdrawal symptoms more intense than expected, or after several failed attempts.
Treatment
Smoking cessation treatment combines behavioral intervention and pharmacotherapy. The three first-line pharmacotherapies — nicotine replacement therapy (NRT), varenicline, and bupropion — are effective and safe. The combination of counseling and medication is more effective than any approach in isolation.
PHARMACOTHERAPY FOR SMOKING CESSATION
| TREATMENT | MECHANISM | CESSATION RATE (6 MONTHS) | CONSIDERATIONS |
|---|---|---|---|
| Varenicline (Champix) | Partial nAChR agonist — reduces craving and dulls the pleasure of smoking | 25-35% | Most effective as monotherapy. Nausea is the most common side effect. |
| NRT (patch + gum/lozenge) | Nicotine replacement — reduces withdrawal without combustion | 20-25% | Combined forms (patch + rescue) outperform any single form. |
| Bupropion | Inhibition of dopamine and norepinephrine reuptake | 15-25% | Especially useful with comorbid depression. Reduces weight gain. |
| Varenicline + NRT | Combination of mechanisms | 30-40% | Reserved for high dependence. Well tolerated in studies. |
Weeks 1-2 (pré-cessation)
Assess dependence (Fagerstrom). Set the quit date. Start varenicline or bupropion (both need 1-2 weeks of titration before quit day).
Quit Day and Week 1
Quit abruptly. Withdrawal peaks (days 2-3). Full pharmacological support. Manage craving with the 4 Ds: delay, drink water, do something, deep breathe.
Weeks 2-4
Physical symptoms gradually improve. Continue pharmacotherapy. Identify and manage behavioral triggers.
Months 1-3
Physical withdrawal resolved. Situational craving persists. Focus on relapse prevention and handling high-risk situations.
Months 3-6
Consolidate gains. Gradually taper NRT if applicable. Continue varenicline for 12-24 weeks depending on response.
Acupuncture as Treatment
Acupuncture, especially auriculotherapy, is widely used as a complementary therapy for smoking cessation. Proposed mechanisms include endorphin release that reduces craving, modulation of the dopaminergic reward system, parasympathetic activation via the vagus nerve, and reduction of anxiety associated with withdrawal.
Stimulating specific auricular points may modulate vagus nerve activity and influence brain centers involved in dependence. Complementary body acupuncture may reduce stress and irritability — withdrawal symptoms that often precipitate relapse.
Acupuncture is used to complement conventional cessation therapies. It can be especially useful for patients who want an integrative approach or have contraindications to conventional pharmacotherapy.
Prognosis
With appropriate treatment, long-term cessation rates (12 months) range from 20-35% — significantly better than the 3-5% seen without treatment. Most successful ex-smokers tried to quit more than once before succeeding definitively. Each attempt increases the chance of future success.
Health benefits begin quickly: blood pressure normalizes within 20 minutes, smell and taste improve in 48 hours, and lung function improves significantly within 3 months. At 1 year, cardiovascular risk drops by half. At 10-15 years, lung cancer risk approaches that of nonsmokers.
Relapse is common and should be seen not as failure but as part of recovery. Relapse risk is highest in the first 3 months. The most frequent triggers are stressful situations, alcohol, and exposure to other smokers.
Myths and Facts
Myth vs. Fact
Quitting smoking is just a matter of willpower.
Nicotine dependence is a chronic disease with a neurobiological basis. Nicotine causes persistent neuroadaptations in reward circuits that make cessation extremely difficult without support. Pharmacological treatment triples the chances of success — needing help is not 'weakness'.
Myth vs. Fact
The e-cigarette is a safe way to quit smoking.
Although e-cigarettes contain fewer toxins than conventional cigarettes, they are not risk-free. Their long-term effects remain unknown, and most countries have not approved them as cessation treatment. Proven therapies — varenicline, NRT, and bupropion — are preferable.
Myth vs. Fact
Cutting down gradually is better than quitting all at once.
Evidence shows that quitting abruptly matches or beats gradual reduction. Abrupt cessation with pharmacological support is the most studied and most recommended method. For smokers who cannot stop abruptly, however, gradual reduction with NRT is a valid alternative.
When to Seek Help
If you want to quit smoking, the best time to seek help is now. Appropriate treatment makes all the difference. You do not have to go through this alone.
Frequently Asked Questions about Smoking Cessation
Nicotine withdrawal symptoms include: intense craving (the most prominent); irritability, frustration, or anger; anxiety; trouble concentrating; restlessness; depressed mood; increased appetite and weight gain; insomnia; and mild bradycardia. Symptoms peak at 24-72 hours and steadily improve over 2-4 weeks. Craving can linger for months, especially when triggered by specific cues such as coffee, alcohol, or stress.
Behavioral counseling plus pharmacotherapy produces the highest success rates — four times higher than trying to quit unaided. First-line pharmacotherapies are: Nicotine Replacement Therapy (NRT) in various forms (patch, gum, nasal spray, inhaler); varenicline (Champix), a partial nicotinic-receptor agonist and the most effective option; and bupropion. Combinations such as patch plus nicotine gum boost efficacy, and behavioral support (regular consultations, helplines) strengthens the medications.
Acupuncture — especially auriculotherapy (auricular acupuncture) — has been studied as an adjunct for smoking cessation. Systematic reviews show mixed results, though some studies report reduced craving and withdrawal symptoms. The proposed mechanism: modulating dopaminergic reward circuits, easing anxiety and stress, and acting on specific points linked to the respiratory system. Use acupuncture to complement established pharmacotherapies, not to replace them.
On average, smokers make 8-10 attempts before achieving definitive abstinence. This does not mean failure — each attempt offers learning about triggers, strategies that work, and strategies that do not. Relapse is part of the process for most people. The important message: relapsing is not "going back to square one" — each period of abstinence has health benefits. After a relapse, the ideal is to identify what triggered it, adjust the plan, and try again with more robust support.
E-cigarettes (vapes) contain nicotine and remain debated as harm-reduction tools. Some studies suggest they may outperform NRT, but the evidence is still limited and of variable quality. The UK NHS accepts them as a cessation tool in supervised settings. In Brazil, e-cigarettes are not regulated as medication, and their long-term risks remain unknown. Varenicline and NRT have more robust evidence and established regulation.
Weight gain is common but variable — averaging 4-5 kg in the first year. The mechanisms: nicotine suppresses appetite, raises basal metabolism, and lowers caloric absorption efficiency; without it, appetite climbs and metabolism slows. To minimize the gain, increase physical activity (which also blunts craving), keep a regular diet without extreme restriction, replace the oral habit with healthier alternatives, and use pharmacotherapies that curb weight gain (varenicline). Importantly, post-cessation weight gain is clinically trivial next to the risks of continued smoking.
Recovery starts at once: 20 minutes — BP and HR normalize; 8 hours — blood CO2 normalizes; 24 hours — MI risk starts to fall; 48 hours — olfactory and gustatory nerves regenerate; 2 weeks — circulation and lung function improve; 1 month — cough and dyspnea ease; 1 year — coronary disease risk drops 50%; 5 years — stroke risk matches a nonsmoker's; 10 years — lung cancer risk drops 50%; 15 years — cardiovascular risk matches a nonsmoker's.
Effective techniques to manage craving: the 5-minute rule — craving usually lasts less than 5 minutes; active distraction (physical activity, calling someone); diaphragmatic breathing techniques; moving away from the trigger; using NRT (fast-acting nicotine gum or spray) when craving is intense; recalling concrete reasons to quit; and recording the craving without acting ("surfing" the urge). Identifying and avoiding main triggers in the first weeks (alcohol, coffee in certain contexts) reduces exposure.
Yes, temporarily. Nicotine has a short-term anxiolytic effect — smokers often use cigarettes as emotional regulators. During withdrawal, anxiety can rise in the first weeks while the nervous system readapts. The good news: longitudinal studies show that after a few months of abstinence, ex-smokers have LOWER baseline anxiety than active smokers. The anxiety a cigarette seems to relieve is partly nicotine withdrawal itself being soothed. Anxiety-management techniques (breathing, mindfulness) and professional support help during this period.
Ideally, every smoker who wants to quit should seek medical support — success rates with help are far higher. Seeking help is especially advised if: you have already tried several times without success; previous attempts brought psychiatric symptoms (depression, intense anxiety); you smoke heavily (>20 cigarettes/day); cardiovascular or pulmonary disease makes cessation urgent; or you use other substances at the same time. A physician can prescribe the right pharmacotherapy and coordinate behavioral support.
Related Reading
Deepen your knowledge with related articles